แบบทดสอบที่เชื่อมโยงกับคำแนะนำ · ปานกลาง ระดับ

แบบทดสอบ AI ในการคัดกรองวัณโรค

Tests WHO CAD screening guidance, age scope, screening versus diagnosis, confirmatory pathways, and local quality monitoring for TB.

เส้นทางแนะนำที่เกี่ยวข้องAI ในการคัดกรองวัณโรค
คำถาม 1 ของ 8

In the WHO screening pathway, what does CAD contribute before diagnostic testing?

ดูตัวอย่างทุกคำถาม8 คำถาม

คำตอบและคำอธิบายจะปรากฏขึ้นเมื่อคุณทำแบบทดสอบ

  1. In the WHO screening pathway, what does CAD contribute before diagnostic testing?
    • Replace treatment services after a positive score
    • Screen every child and adult under the same recommendation
    • Help interpret chest X-rays and identify people for further evaluation
    • Confirm TB diagnosis without additional testing
  2. Which age scope did WHO’s 2025 CAD statement address?
    • Children younger than 15 only
    • People aged 15 years and older, with no recommendation for younger children
    • Only infants under one year
    • Every age group with the same performance claim
  3. What should follow a positive CAD screening result?
    • A final diagnosis from the score alone
    • Treatment chosen automatically by the algorithm
    • No follow-up unless a second AI tool agrees
    • Confirmatory diagnostic evaluation under the local TB program
  4. How should an unreadable chest X-ray be interpreted?
    • As a test that needs the program’s repeat or referral process
    • As negative for TB
    • As proof the patient has TB
    • As a reason to bypass confirmatory testing
  5. What should a program monitor after deploying TB CAD?
    • Whether the model score is displayed in color
    • Image quality, threshold performance, referrals, and confirmatory-test completion
    • Only how fast the software opens
    • Only the total number of images uploaded
  6. Why can a CAD threshold need local evaluation?
    • Thresholds never affect screening results
    • Every population has identical disease prevalence
    • The threshold determines which chest X-ray machine is used
    • Disease prevalence and population characteristics can change the balance of missed cases and referrals
  7. What does a low CAD score establish?
    • Only that the software did not cross its screening threshold for that image
    • That active TB is impossible
    • That a person with symptoms never needs evaluation
    • That the image was technically perfect
  8. Why should programs use current WHO product guidance?
    • A historical benchmark covers every new device
    • A model update automatically guarantees improved performance
    • The evaluated products and recommendations can change as evidence and software versions change
    • The first product ever evaluated remains approved for all settings